We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

103 hedge funds and large institutions have $611M invested in Coherus Oncology in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $1.99M | Put options by funds: $983K

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

40% more capital invested

Capital invested by funds: $436M → $611M (+$175M)

34% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 29

10% more funds holding

Funds holding: 94 → 103 (+9)

6.53% more ownership

Funds ownership: 85.4% → 91.94% (+6.5%)

Holders
103
Holders Change
+9
Holders Change %
+9.57%
% of All Funds
2.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
39
Reduced
29
Closed
13
Calls
$1.99M
Puts
$983K
Net Calls
+$1.01M
Net Calls Change
+$1.43M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.78M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.27M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.76M
4
RCMNY
Rubric Capital Management (New York)
New York
+$5.07M
5
HCM
Highbridge Capital Management
New York
+$4.1M

Top Sellers

Rank Fund Capital Flow
1
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$6.04M
2
Millennium Management
Millennium Management
New York
-$5.86M
3
State Street
State Street
Massachusetts
-$2.03M
4
HCMT
Highland Capital Management (Texas)
Texas
-$1.6M
5
Ameriprise
Ameriprise
Minnesota
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
Daiwa Securities Group
101
Daiwa Securities Group
Japan
$4K +$3.5K +320 New
APA
102
American Portfolios Advisors
New York
$1.34K +$1.32K +121 New
FRM
103
Fox Run Management
Connecticut
– -$228K -25,950 Closed
PVI
104
Pura Vida Investments
New York
– -$274K -25,000 Closed
Franklin Resources
105
Franklin Resources
California
– -$211K -24,000 Closed
Squarepoint
106
Squarepoint
New York
– -$203K -23,032 Closed
LCM
107
Landscape Capital Management
New Jersey
– -$116K -13,148 Closed
Teacher Retirement System of Texas
108
Teacher Retirement System of Texas
Texas
– -$101K -11,448 Closed
CSS
109
Cubist Systematic Strategies
Connecticut
– -$97K -11,033 Closed
II
110
Inspire Investing
Idaho
– -$57K -6,431 Closed
TRCT
111
Tower Research Capital (TRC)
New York
– -$25K -2,819 Closed
Pacer Advisors
112
Pacer Advisors
Pennsylvania
– -$15K -1,725 Closed
PHK
113
Point72 Hong Kong
Hong Kong
– -$14K -1,638 Closed
MAM
114
Meeder Asset Management
Ohio
– -$1K -99 Closed
S
115
SignatureFD
Georgia
– +$55 +5 New
1 2 3 4
5

CHRS Hedge Fund Activity: Q1 2018 in Review

103 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2018, worth a combined $611M — up 40% from $436M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CHRS positions and 13 closed out — a net gain of 10 holders — while 39 added to existing stakes and 29 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $8.78M. The largest seller was State of Wisconsin Investment Board, cutting an estimated $6.04M.

  • 103 institutional investors held Coherus Oncology (CHRS) as of Q1 2018, up from 94 in Q4 2017.
  • Funds reported $611M of Coherus Oncology stock for Q1 2018, up 40% quarter-over-quarter.
  • 23 funds opened new Coherus Oncology positions in Q1 2018 and 13 closed out, a net change of +10 holders.
  • The largest Coherus Oncology buyer in Q1 2018 was Fidelity Investments, an estimated $8.78M added.
  • The largest Coherus Oncology seller in Q1 2018 was State of Wisconsin Investment Board, an estimated $6.04M sold.

Based on aggregated 13F filings for Q1 2018.